← FDA DRUG APPROVALS

FDA ANDA · ANDA074334

VECURONIUM BROMIDE

Sponsor: WATSON LABS

APPLICATION
ANDA074334
TYPE
ANDA
ORIGINAL APPROVAL
1995-08-31
LATEST ACTION
2017-07-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

VECURONIUM BROMIDEDiscontinued
VECURONIUM BROMIDE 10MG/VIAL · INJECTABLE · INJECTION
VECURONIUM BROMIDEDiscontinued
VECURONIUM BROMIDE 20MG/VIAL · INJECTABLE · INJECTION

Approval history

2017-07-21Labeling · Supplement 37AP
2001-07-23Manufacturing (CMC) · Supplement 22AP
2000-11-30Manufacturing (CMC) · Supplement 20AP
2000-11-30Labeling · Supplement 21AP
2000-08-30Manufacturing (CMC) · Supplement 14AP
2000-08-30Manufacturing (CMC) · Supplement 13AP
2000-06-27Manufacturing (CMC) · Supplement 18AP
2000-06-27Manufacturing (CMC) · Supplement 19AP
2000-06-27Manufacturing (CMC) · Supplement 17AP
2000-02-24Manufacturing (CMC) · Supplement 16AP
2000-02-24Manufacturing (CMC) · Supplement 15AP
1999-02-19Manufacturing (CMC) · Supplement 11AP
1999-02-02Manufacturing (CMC) · Supplement 9AP
1998-09-03Manufacturing (CMC) · Supplement 10AP
1998-02-27Labeling · Supplement 8AP
1997-04-07Manufacturing (CMC) · Supplement 2AP
1997-04-07Manufacturing (CMC) · Supplement 5AP
1997-04-07Manufacturing (CMC) · Supplement 3AP
1997-04-03Manufacturing (CMC) · Supplement 6AP
1997-04-03Manufacturing (CMC) · Supplement 7AP
1997-02-27Labeling · Supplement 1AP
1996-12-04Manufacturing (CMC) · Supplement 4AP
1995-08-31OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →